Frontiers | Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Conditional transcriptional relationships may serve as cancer prognostic markers | BMC Medical Genomics | Full Text
Cancers | Free Full-Text | Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
THEMIS2 was able to promote cancer stemness properties in TNBC cells A... | Download Scientific Diagram
Frontiers | Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors
The 5 Tumor Markers You Must Know About Lung Cancer - Mindray Global
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome
Cancers | Free Full-Text | AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma
PHGDH heterogeneity potentiates cancer cell dissemination and metastasis | Nature
JCI - Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells
The value of cancer antigen 125 ( Ca 125 ) and copeptin as markers in patients with advanced heart failure | Semantic Scholar
Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes | Journal for ImmunoTherapy of Cancer | Full Text
MSI analysis of breast cancer by size of microsatellite marker repeat... | Download Scientific Diagram
Cancers | Free Full-Text | Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer
![PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f7bb4eb6de25f6ecb9323cbef8061896f020a0da/2-Figure1-1.png "PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar")
PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar
Effects of Repeated 131I-Meta-Iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activity in Patients with Metastatic Neuroendocrine Tumors | Journal of Nuclear Medicine
Proteome activity landscapes of tumor cell lines determine drug responses | Nature Communications
Tumor-Associated Trypsin Inhibitor (Tati) in Benign and Malignant Gastric Disease
Multiplex Cancer Assays for Cancer Biomarker Detection | MILLIPLEX® Assays
